Tag: BUPI

November 8, 2016

Moberg Pharma Announces Interim Report for January – September 2016

Total net sales in Q3 increased by 56% (56% at fixed exchange rates). Net sales excluding divestments and acquisitions increased...
November 4, 2016

Moberg Pharma’s Nomination Committee Appointed

In accordance with the resolution of the Annual General Meeting on May 18, 2016, the Chairman of the Board has...
October 19, 2016

Moberg Pharma Receives European Patent for BUPI

Moberg Pharma announced that the European Patent Office has issued Patent No. 2701681 which protects BUPI, currently in development for...
September 28, 2016

Moberg Pharma Begins Patient Enrollment in Two Phase 3 Studies of MOB-015

Moberg Pharma today announced that patient enrollment has started in U.S., Canada and Germany in the Phase 3 program investigating...